This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Remitogen

PDL BioPharma, Inc.

Drug Names(s): SMART-1D10, Hu1D10

Description: Remitogen is an antibody for non-Hodgkin's B-cell lymphoma Remitogen is a humanized antibody that binds to the 1D10 antigen, an HLA- DR determinant found on many pre-B and B-cell lymphomas. The 1D10 antigen also is present on cancer cells from acute and chronic lymphocytic leukemia patients, as well as on some solid tumors.


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug